When several cancer sites are found in one breast, the surgical decision depends on more than their number. Two small areas close together and abnormalities in widely separated parts of the breast create different problems. “Multifocal” is a useful descriptive term, but it does not by itself establish whether breast conservation is possible or how much tissue must be removed.
The records should distinguish the side, location and size of each focus, as well as the extent of the entire suspicious area. The surgeon needs to know which findings have been confirmed by biopsy, which remain uncertain and how the sites relate to one another. A summary saying only “three lesions” loses information that is important for planning.
Provide the original mammogram and ultrasound files, and the complete MRI study if one has been performed, together with the reports. Photographs of a few selected images do not allow the same review as the complete study. You do not need to draw the operation boundaries yourself; the practical task is to preserve the investigations and their correct labels.
The ASBrS resource guide on breast-conserving surgery describes mammography with supplementary ultrasound or MRI when needed to define disease extent. It also discusses conservation in selected patients with multiple foci. That is a reason for individual assessment, not a promise that any pattern of multiple tumours can be treated with a small operation.
Another investigation is useful when its findings could change the decision. For example, before a newly seen area leads to a larger operation, the team should explain how certain they are about its nature and whether confirmation is needed. More scans do not automatically create a more reliable plan. Sometimes the missing step is comparison of existing studies; sometimes a targeted investigation is required.
The surgeon considers whether all necessary areas can be removed with satisfactory margins while retaining an acceptable breast shape. The discussion also includes subsequent radiotherapy and the patient’s preferences. Conservation is usually a treatment pathway rather than simply a smaller incision. The NCI comparison of lumpectomy and mastectomy explains the broader differences between these approaches.
Ask the surgeon to mark the proposed areas on a diagram and explain the reason for each. If oncoplastic surgery is suggested, discuss the likely change in breast shape and how a further procedure would be approached if the margins were unsatisfactory. If mastectomy is recommended, establish which feature makes conservation unsuitable. Advertising photographs cannot resolve that question for an individual breast.
The surgical review needs imaging from before systemic treatment as well as the later studies. The latest scan shows the current appearance; the initial study identifies the original confirmed sites. Keep the biopsy procedure reports and marker details too. Without them, a small residual finding may be difficult to connect to the original distribution of disease.
Do not merge the pathology from several samples into one line. Separate sites can have different descriptions, whose significance the clinical team must interpret. Dates are equally useful: the reviewer needs to know which results preceded treatment and which followed it, rather than mistaking a change in appearance for inconsistent paperwork.
For an oncology second opinion, a useful question is: “Can all confirmed sites be removed while preserving the breast, and what information is still needed to answer that?” The written recommendation should connect the proposed operation to the actual distribution of findings.
Also establish which studies do not need repeating and which missing information is necessary before a visit to Turkey. That turns a comparison of operation names and prices into a discussion of the particular surgical problem, the remaining uncertainty and the choices available to you.
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.